Monaghan Medical and Premier announced their agreement to a three-year contract, effective May 1, 2023, creating a partnership between two healthcare industry leaders. Under the terms of the agreement, Monaghan will provide Premier members with respiratory devices in two categories: Respiratory Therapy Medication Delivery devices and Oscillatory Positive Expiratory Pressure/Positive Airway Pressure devices. The signed agreement recognizes Monaghan’s reputation for both industry leading technology and proven clinical outcomes. Clinical evidence shows that Monaghan medical devices deliver superior patient outcomes. Monaghan’s reputation for gold-standard medical devices aligns with Premier’s desire to drive process efficiencies and value-driven healthcare spending.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PINC: